FALBIKITUG
UNII E4JL3K3CI6

Substance Identification & Data

This profile provides standardized clinical and technical data for Falbikitug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) E4JL3K3CI6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2740565-02-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

E4JL3K3CI6

CAS Registry Number

2740565-02-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

FALBIKITUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C156176

National Cancer Institute reference terminology for clinical and research data.

INN ID

12512

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-257

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Falbikitug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FALBIKITUG

Common Names & Synonyms

FALBIKITUG [INN]

FALBIKITUG [USAN]

FALBIKITUG [WHO-DD]

GAMMA1 HEAVY CHAIN HUMANIZED (1-448) (VH (HOMO SAPIENS IGHV3-15*07 (86.9%)--(IGHD) -IGHJ1*01(90.9%), CDR-IMGT (8.10.9) (26-33.51-60.99-107))(1-118) -HOMO SAPIENS IGHG1*01 (100%), G1M17,1 CH1K120, CH3 D12, L14 (CH1 K120 (215) (119-216),HINGE 1-15 (217-231), CH2 (232-341), CH3 D12 (357), L14 (359) (342-446), CHS (447-448)) (119-448)), (221-220')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-220') (V-KAPPA (HOMO SAPIENS IGKV2-24*01 (90.0%)-IGKJ2*01 (100%), CDR-IMGT (11.3.10) (27-37.55-57.94-103)) (1'-113') -HOMO SAPIENS IGKC*01 (100%), KM3, A45.1 (159), V101 (197) (114'-220')); DIMER (227-227'':230-230'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, DERIVED FROM THE CELL LINE CHO-K1, GLYCOFORM ALFA

IMMUNOGLOBULIN G1, ANTI-(HUMAN LEUKEMIA INHIBITORY FACTOR) (HUMAN-WISTAR RAT MONOCLONAL AZD0171 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-WISTAR MONOCLONAL AZD0171 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS LIF (LIF INTERLEUKIN 6 FAMILY CYTOKINE, LEUKEMIA INHIBITORY FACTOR)), HUMANIZED MONOCLONAL ANTIBODY